Financial reports
10-Q
2024 Q2
Quarterly report
1 Feb 24
10-Q
2024 Q1
Quarterly report
2 Nov 23
ARS
2023 FY
Annual report to shareholders
27 Sep 23
10-K
2023 FY
Annual report
8 Aug 23
10-Q
2023 Q3
Quarterly report
2 May 23
10-Q
2023 Q2
Quarterly report
2 Feb 23
10-Q
2023 Q1
Quarterly report
2 Nov 22
10-K
2022 FY
Annual report
12 Aug 22
10-Q
2022 Q3
Quarterly report
3 May 22
10-Q
2022 Q2
Quarterly report
1 Feb 22
Current reports
8-K/A
Regulation FD Disclosure
29 Feb 24
8-K
Regulation FD Disclosure
28 Feb 24
8-K
Broadridge Declares Quarterly Dividend of $0.80 Per Share
16 Feb 24
8-K
Broadridge Reports Second Quarter Fiscal 2024 Results
1 Feb 24
8-K
Broadridge Highlights Path for Sustainable Long-term Growth
7 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
13 Nov 23
8-K
Broadridge Declares Quarterly Dividend of $0.80 Per Share
9 Nov 23
8-K
Broadridge Reports First Quarter Fiscal 2024 Results
2 Nov 23
8-K
Regulation FD Disclosure
13 Sep 23
8-K
Michael Tae and Doug DeSchutter Appointed Co-Presidents of
6 Sep 23
Registration and prospectus
S-3ASR
Automatic shelf registration
12 Aug 22
424B5
Prospectus supplement for primary offering
7 May 21
FWP
Free writing prospectus
6 May 21
424B5
Prospectus supplement for primary offering
6 May 21
424B5
Prospectus supplement for primary offering
5 Dec 19
FWP
Free writing prospectus
4 Dec 19
424B5
Prospectus supplement for primary offering
4 Dec 19
S-3ASR
Automatic shelf registration
7 Aug 19
S-8
Registration of securities for employees
16 Nov 18
424B5
Prospectus supplement for primary offering
23 Jun 16
Proxies
DEFA14A
Additional proxy soliciting materials
27 Sep 23
DEF 14A
Definitive proxy
27 Sep 23
DEFA14A
Additional proxy soliciting materials
7 Oct 22
DEFA14A
Additional proxy soliciting materials
27 Sep 22
DEF 14A
Definitive proxy
27 Sep 22
DEFA14A
Additional proxy soliciting materials
5 Oct 21
DEF 14A
Definitive proxy
5 Oct 21
DEFA14A
Additional proxy soliciting materials
27 Oct 20
DEFA14A
Additional proxy soliciting materials
6 Oct 20
DEFA14A
Additional proxy soliciting materials
6 Oct 20
Other
UPLOAD
Letter from SEC
21 Apr 22
CORRESP
Correspondence with SEC
5 Apr 22
UPLOAD
Letter from SEC
22 Mar 22
CT ORDER
Confidential treatment order
19 Feb 20
CT ORDER
Confidential treatment order
19 Feb 20
CT ORDER
Confidential treatment order
19 Feb 20
CT ORDER
Confidential treatment order
19 Feb 20
UPLOAD
Letter from SEC
27 Jun 19
CORRESP
Correspondence with SEC
3 Jun 19
CORRESP
Correspondence with SEC
25 Apr 19